248 studies found for:    "Eye Diseases, Hereditary" OR "Lenz microphthalmia syndrome"
Show Display Options
Rank Status Study
21 Enrolling by invitation New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression
Condition: Thyroid-Associated Ophthalmopathy
Interventions: Procedure: Autologous fat injection;   Procedure: Hyaluronic acid injection
22 Recruiting A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution for the Treatment of Leber's Hereditary Optic Neuropathy
Condition: Leber's Hereditary Optic Neuropathy
Interventions: Drug: elamipretide (MTP-131) 1% topical ophthalmic solution;   Drug: Vehicle topical ophthalmic solution
23 Enrolling by invitation THOR - Tübingen Choroideremia Gene Therapy Trial
Condition: Choroideremia
Intervention: Genetic: rAAV2.REP1
24 Recruiting Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy
Conditions: Retinitis Pigmentosa;   Cone Rod Dystrophy;   Choroideremia
Intervention: Device: Intelligent Retinal Implant System
25 Recruiting Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
Conditions: Macular Oedema;   Retinitis Pigmentosa
Intervention: Drug: Aflibercept
26 Recruiting Study of Ataluren in Patients With Aniridia
Condition: Aniridia
Interventions: Drug: Ataluren;   Drug: Placebo
27 Recruiting Rod and Cone Mediated Function in Retinal Disease
Conditions: Retinal Degeneration;   Retinitis Pigmentosa;   Stargardt's Disease
Intervention:
28 Not yet recruiting AUgmented REality for the Visually Impaired - Part 1
Conditions: Retinitis Pigmentosa;   Glaucoma
Interventions: Procedure: Find visual comfort threshold related to light intensity;   Procedure: Find the size of the visual field;   Procedure: Effectiveness of brightness control;   Procedure: Performance of color correction;   Device: Vuzix Wrap 1200DX virtural reality glasses
29 Active, not recruiting Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
Conditions: Retinitis Pigmentosa;   Cystoid Macular Edema
Interventions: Drug: rhNGF 180 µg/ml eye drops solution;   Drug: vehicle eye drops
30 Not yet recruiting Post-Marketing Surveillance of Patients Using the Subretinal Retina Implant Alpha
Condition: Retinitis Pigmentosa
Intervention:
31 Completed Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT
Conditions: Leber Congenital Amaurosis (LCA);   Retinitis Pigmentosa (RP)
Intervention: Other: No treatment: retrospective chart review
32 Recruiting RST-001 Phase I/II Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: RST-001
33 Active, not recruiting Choroideremia Gene Therapy Clinical Trial
Condition: Choroideremia
Intervention: Genetic: Injection of AAV2-REP1 (10e11 vg)
34 Not yet recruiting Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study
Condition: Retinitis Pigmentosa
Intervention: Device: Transcorneal Electrical Stimulation using Okustim device
35 Not yet recruiting Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT
Condition: Fuchs' Endothelial Dystrophy
Intervention: Device: Ultrahigh resolution Spectral Domain OCT
36 Recruiting The Effects of Metformin in Patients With Mild Graves' Ophthalmopathy
Condition: Mild Graves' Ophthalmopathy
Interventions: Drug: Metformin;   Drug: Placebo
37 Recruiting Technique And Results In Endothelial Keratoplasty
Conditions: Corneal Endothelial Cell Loss;   Fuchs' Endothelial Dystrophy
Interventions: Procedure: Descemet Stripping Automated Endothelial Keratoplasty;   Procedure: Descemet Membrane Endothelial Keratoplasty
38 Not yet recruiting Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Continuous oxygen;   Device: blue light-absorbing sunglasses;   Drug: Compound thrombosis capsule sig: 1.5g/tid;   Drug: Ginkgo biloba pills sig: 300mg/tid;;   Drug: Vitamin B sig: 10mg/tid;   Drug: Vitamin AD sig: 1 tablet/tid
39 Recruiting Safety and Tolerability of hRPC in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: hRPC
40 Enrolling by invitation Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients
Conditions: Segmental Vitiligo;   Piebaldism
Interventions: Device: ReCell;   Device: Full surface CO2 laser 200 mJ;   Device: Full surface CO2 laser 150 mJ;   Device: Fractional CO2 laser 7.5 mJ, 20%

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years